An expanded-access program of Avastin [bevacizumab] in patients with metastatic cancer of the colon or rectum
Phase of Trial: Phase IV
Latest Information Update: 23 Feb 2010
At a glance
- Drugs Antineoplastics; Bevacizumab
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Roche
- 18 May 2008 Status changed from in progress to completed, from Roche record.
- 08 Jun 2006 New trial record.